InvestorsHub Logo
Followers 0
Posts 1531
Boards Moderated 0
Alias Born 01/04/2017

Re: hdwrsft post# 15269

Monday, 03/13/2017 6:11:27 PM

Monday, March 13, 2017 6:11:27 PM

Post# of 108192
when i corresponded with Aratana recently they were still enrolling subjects. nice to know that enrollment is finished and that they have moved conditional approval to 2H 2017. progress Lol

one would think that conducting a safety and efficacy study for a drug already shown to be safe and effective would not be a particularly arduous task but, apparently for our marvelous partner, it strains the limits of their capacity. way to go DOC
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News